Shiyu Capital
Private equityHainan · Seed–Late Stage
Investment thesis
Shiyu Capital specializes in equity investment across China's pharmaceutical and healthcare industry, combining deep industry roots with expertise in investment, financial services and capital markets across global and domestic markets. Registered as a private fund manager since November 2015, it manages over RMB 7 billion. Through its flagship Danqing Innovation Pharmaceutical Industry Fund it seeks to capture opportunities in the transformation of China's pharma sector, working closely with entrepreneurs to create value. The firm emphasizes rigorous research, focus, and long-term partnership with portfolio companies. It also runs a children's cancer charity foundation and a related public-health education platform.
Source: firm website, verified Aug 3, 2026.
Frequently asked questions
- What stage does Shiyu Capital invest at?
- Shiyu Capital invests at the Seed, Late Stage stages.
- What sectors does Shiyu Capital focus on?
- Shiyu Capital focuses on Biotech, Digital Health, Healthtech.
- Where is Shiyu Capital located?
- Shiyu Capital is headquartered in Hainan, CN.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.